Objective:
To evaluate the impact of breast cancer treatment on diabetes self-care and management, highlighting its significance for patient outcomes.
Approach:
- Diabetes self-care declined during breast cancer treatment, with reduced adherence to diet, physical activity, glucose monitoring, and medication use, contributing to increased emotional distress.
- Treatment-related symptoms disrupted established diabetes routines, complicating self-management.
- 60% of patients reported uncontrolled glucose levels during treatment, with nearly half exceeding 200 mg/dL.
- Cancer-related post-traumatic stress significantly impacted perceived diabetes control and emotional well-being.
- Higher symptom burden correlated with poorer diabetes self-management and reduced physical function.
- Variation in study design, sample size, and outcome measures limited the evidence base, impacting generalizability.
- Most studies were conducted in the US with small sample sizes.
- The quasi-experimental study lacked a control group, and cross-sectional studies did not establish causal relationships.
Key Findings:
Interpretation:
The findings indicate that breast cancer treatment adversely affects diabetes management, leading to increased emotional distress and potential health complications, underscoring the need for integrated care.
Limitations:
Conclusion:
Diabetes self-care declines during breast cancer treatment, increasing the risk of poorer health outcomes and diabetes-related complications. A personalized diabetes care model showed promise in improving management and warrants further investigation.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
